Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy

NCT07185945 is registered in ClinicalTrials.gov with Guru Sonpavde as lead sponsor.

NCT NCT07185945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07185945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy
Lead sponsor
Guru Sonpavde
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
June 30, 2029
Enrollment
44 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced urothelial carcinoma